# EXPAND ENERGY Corp: financial statements, quarterly

EXE · Nasdaq · CIK 895126 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exe.md) · [Financials](/companies/exe/financials.md) · [Filings](/companies/exe/filings.md) · [Insiders](/companies/exe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/exe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,948 d](/filings/0000895126-26-000011.md) | [1,081](/filings/0000895126-25-000053.md) | [505](/filings/0000895126-25-000084.md) | [648](/filings/0000895126-25-000098.md) | [2,001 d](/filings/0000895126-26-000011.md) | [2,196](/filings/0000895126-26-000028.md) | [3,690](/filings/0000895126-26-000047.md) | [2,966](/filings/0000895126-26-000068.md) | [3,272 d](/filings/0000895126-26-000011.md) | [4,397](/filings/0000895126-26-000028.md) | [2,960](/filings/0000895126-26-000047.md) | [3,286](/filings/0000895126-26-000068.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [726 d](/filings/0000895126-26-000011.md) | [32.0](/filings/0000895126-25-000053.md) | [(294)](/filings/0000895126-25-000084.md) | [(155)](/filings/0000895126-25-000098.md) | [(386) d](/filings/0000895126-26-000011.md) | [(268)](/filings/0000895126-26-000028.md) | [1,269](/filings/0000895126-26-000047.md) | [725](/filings/0000895126-26-000068.md) | [745 d](/filings/0000895126-26-000011.md) | [1,531](/filings/0000895126-26-000028.md) | [661](/filings/0000895126-26-000047.md) | [640](/filings/0000895126-26-000068.md) |
| Interest expense | $m | [22.0 d](/filings/0000895126-24-000013.md) | [19.0](/filings/0000895126-24-000055.md) | [20.0](/filings/0000895126-25-000084.md) | [20.0](/filings/0000895126-25-000098.md) | [64.0 d](/filings/0000895126-26-000011.md) | [59.0](/filings/0000895126-26-000028.md) | [60.0](/filings/0000895126-26-000047.md) | [57.0](/filings/0000895126-26-000068.md) | [59.0 d](/filings/0000895126-26-000011.md) | [59.0](/filings/0000895126-26-000028.md) | [43.0](/filings/0000895126-26-000047.md) | [44.0](/filings/0000895126-26-000068.md) |
| Income tax | $m | [166 d](/filings/0000895126-26-000011.md) | [7.0](/filings/0000895126-25-000053.md) | [(68.0)](/filings/0000895126-25-000084.md) | [(44.0)](/filings/0000895126-25-000098.md) | [(22.0) d](/filings/0000895126-26-000011.md) | [(70.0)](/filings/0000895126-26-000028.md) | [260](/filings/0000895126-26-000047.md) | [139](/filings/0000895126-26-000068.md) | [134 d](/filings/0000895126-26-000011.md) | [330](/filings/0000895126-26-000028.md) | [150](/filings/0000895126-26-000047.md) | [89.0](/filings/0000895126-26-000068.md) |
| Net income | $m | [569 d](/filings/0000895126-26-000011.md) | [26.0](/filings/0000895126-25-000098.md) | [(227)](/filings/0000895126-25-000098.md) | [(114)](/filings/0000895126-25-000098.md) | [(399) d](/filings/0000895126-26-000011.md) | [(249)](/filings/0000895126-26-000068.md) | [968](/filings/0000895126-26-000068.md) | [547](/filings/0000895126-26-000068.md) | [553 d](/filings/0000895126-26-000011.md) | [1,159](/filings/0000895126-26-000068.md) | [522](/filings/0000895126-26-000068.md) | [519](/filings/0000895126-26-000068.md) |
| Diluted EPS | $ per share | not reported | [0.18](/filings/0000895126-25-000053.md) | [(1.73)](/filings/0000895126-25-000084.md) | [(0.85)](/filings/0000895126-25-000098.md) | not reported | [(1.06)](/filings/0000895126-26-000028.md) | [4.02](/filings/0000895126-26-000047.md) | [2.28](/filings/0000895126-26-000068.md) | not reported | [4.81](/filings/0000895126-26-000028.md) | [2.19](/filings/0000895126-26-000047.md) | [2.24](/filings/0000895126-26-000068.md) |
| Basic EPS | $ per share | not reported | [0.20](/filings/0000895126-25-000053.md) | [(1.73)](/filings/0000895126-25-000084.md) | [(0.85)](/filings/0000895126-25-000098.md) | not reported | [(1.06)](/filings/0000895126-26-000028.md) | [4.07](/filings/0000895126-26-000047.md) | [2.30](/filings/0000895126-26-000068.md) | not reported | [4.83](/filings/0000895126-26-000028.md) | [2.19](/filings/0000895126-26-000047.md) | [2.24](/filings/0000895126-26-000068.md) |

- Revenue: us-gaap:Revenues
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0000895126-26-000011.md) | [1.2](/filings/0000895126-25-000053.md) | [1.0](/filings/0000895126-25-000084.md) | [1.0](/filings/0000895126-25-000098.md) | [0.3](/filings/0000895126-26-000011.md) | [0.3](/filings/0000895126-26-000028.md) | [0.7](/filings/0000895126-26-000047.md) | [0.6](/filings/0000895126-26-000068.md) | [0.6](/filings/0000895126-26-000068.md) | [2.2](/filings/0000895126-26-000028.md) | [0.7](/filings/0000895126-26-000047.md) | [0.1](/filings/0000895126-26-000068.md) |
| Current assets | $bn | [2.6](/filings/0000895126-25-000021.md) | [2.4](/filings/0000895126-24-000055.md) | [2.0](/filings/0000895126-24-000108.md) | [1.8](/filings/0000895126-24-000135.md) | [2.0](/filings/0000895126-26-000011.md) | [2.1](/filings/0000895126-25-000053.md) | [2.3](/filings/0000895126-25-000084.md) | [2.2](/filings/0000895126-25-000098.md) | [2.9](/filings/0000895126-26-000068.md) | [4.4](/filings/0000895126-26-000028.md) | [2.8](/filings/0000895126-26-000047.md) | [3.1](/filings/0000895126-26-000068.md) |
| Total assets | $bn | [14.4](/filings/0000895126-25-000021.md) | [14.0](/filings/0000895126-24-000055.md) | [13.6](/filings/0000895126-24-000108.md) | [13.4](/filings/0000895126-24-000135.md) | [27.9](/filings/0000895126-26-000011.md) | [27.9](/filings/0000895126-25-000053.md) | [27.8](/filings/0000895126-25-000084.md) | [27.6](/filings/0000895126-25-000098.md) | [28.3](/filings/0000895126-26-000068.md) | [29.5](/filings/0000895126-26-000028.md) | [28.0](/filings/0000895126-26-000047.md) | [29.7](/filings/0000895126-26-000068.md) |
| Current liabilities | $bn | [1.3](/filings/0000895126-25-000021.md) | [1.0](/filings/0000895126-24-000055.md) | [0.9](/filings/0000895126-24-000108.md) | [0.9](/filings/0000895126-24-000135.md) | [3.1](/filings/0000895126-26-000011.md) | [3.6](/filings/0000895126-25-000053.md) | [2.9](/filings/0000895126-25-000084.md) | [2.8](/filings/0000895126-25-000098.md) | [2.9](/filings/0000895126-26-000068.md) | [4.0](/filings/0000895126-26-000028.md) | [3.0](/filings/0000895126-26-000047.md) | [3.4](/filings/0000895126-26-000068.md) |
| Total liabilities | $bn | [3.6](/filings/0000895126-25-000021.md) | [3.3](/filings/0000895126-24-000055.md) | [3.2](/filings/0000895126-24-000108.md) | [3.2](/filings/0000895126-24-000135.md) | [10.3](/filings/0000895126-26-000011.md) | [10.7](/filings/0000895126-25-000053.md) | [9.8](/filings/0000895126-25-000084.md) | [9.5](/filings/0000895126-25-000098.md) | [9.7](/filings/0000895126-26-000068.md) | [10.0](/filings/0000895126-26-000028.md) | [8.6](/filings/0000895126-26-000047.md) | [10.2](/filings/0000895126-26-000068.md) |
| Long-term debt | $bn | [2.0](/filings/0000895126-25-000021.md) | [2.0](/filings/0000895126-24-000055.md) | [2.0](/filings/0000895126-24-000108.md) | [2.0](/filings/0000895126-24-000135.md) | [5.3](/filings/0000895126-26-000011.md) | [5.2](/filings/0000895126-25-000053.md) | [5.1](/filings/0000895126-25-000084.md) | [5.0](/filings/0000895126-25-000098.md) | [5.0](/filings/0000895126-26-000068.md) | [4.1](/filings/0000895126-26-000028.md) | [3.7](/filings/0000895126-26-000047.md) | [4.6](/filings/0000895126-26-000068.md) |
| Current portion of debt | $bn | [0.0](/filings/0000895126-25-000021.md) | not reported | not reported | not reported | [0.4](/filings/0000895126-26-000011.md) | [0.0](/filings/0000895126-25-000053.md) | [0.0](/filings/0000895126-25-000084.md) | [0.0](/filings/0000895126-25-000098.md) | [0.0](/filings/0000895126-26-000028.md) | [0.9](/filings/0000895126-26-000028.md) | not reported | not reported |
| Shareholders' equity | $bn | [10.7](/filings/0000895126-26-000011.md) | [10.7](/filings/0000895126-25-000098.md) | [10.4](/filings/0000895126-25-000098.md) | [10.2](/filings/0000895126-25-000098.md) | [17.6](/filings/0000895126-26-000068.md) | [17.2](/filings/0000895126-26-000068.md) | [17.9](/filings/0000895126-26-000068.md) | [18.2](/filings/0000895126-26-000068.md) | [18.6](/filings/0000895126-26-000068.md) | [19.5](/filings/0000895126-26-000068.md) | [19.4](/filings/0000895126-26-000068.md) | [19.5](/filings/0000895126-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [470 d](/filings/0000895126-26-000011.md) | [552](/filings/0000895126-25-000053.md) | [209 d](/filings/0000895126-25-000084.md) | [422 d](/filings/0000895126-25-000098.md) | [382 d](/filings/0000895126-26-000011.md) | [1,096](/filings/0000895126-26-000028.md) | [1,322 d](/filings/0000895126-26-000047.md) | [1,201 d](/filings/0000895126-26-000068.md) | [956 d](/filings/0000895126-26-000011.md) | [2,402](/filings/0000895126-26-000028.md) | [1,096 d](/filings/0000895126-26-000047.md) | [1,177 d](/filings/0000895126-26-000068.md) |
| Capital expenditure | $m | [379 d](/filings/0000895126-26-000011.md) | [421](/filings/0000895126-25-000053.md) | [302 d](/filings/0000895126-25-000084.md) | [298 d](/filings/0000895126-25-000098.md) | [536 d](/filings/0000895126-26-000011.md) | [563](/filings/0000895126-26-000028.md) | [657 d](/filings/0000895126-26-000047.md) | [775 d](/filings/0000895126-26-000068.md) | [741 d](/filings/0000895126-26-000011.md) | [707](/filings/0000895126-26-000028.md) | [753 d](/filings/0000895126-26-000047.md) | [838 d](/filings/0000895126-26-000068.md) |
| Dividends paid | $m | [75.0 d](/filings/0000895126-26-000011.md) | [77.0](/filings/0000895126-25-000053.md) | [99.0 d](/filings/0000895126-25-000084.md) | [78.0 d](/filings/0000895126-25-000098.md) | [134 d](/filings/0000895126-26-000011.md) | [142](/filings/0000895126-26-000028.md) | [137 d](/filings/0000895126-26-000047.md) | [349 d](/filings/0000895126-26-000068.md) | [137 d](/filings/0000895126-26-000011.md) | [141](/filings/0000895126-26-000028.md) | [138 d](/filings/0000895126-26-000047.md) | [132 d](/filings/0000895126-26-000068.md) |
| Share repurchases | $m | [42.0 d](/filings/0000895126-26-000011.md) | [0.0](/filings/0000895126-24-000055.md) | [0.0 d](/filings/0000895126-25-000084.md) | [0.0 d](/filings/0000895126-25-000098.md) | [0.0 d](/filings/0000895126-26-000011.md) | [0.0](/filings/0000895126-26-000028.md) | [99.0 d](/filings/0000895126-26-000047.md) | [1.0 d](/filings/0000895126-26-000068.md) | [0.0 d](/filings/0000895126-26-000011.md) | [66.0](/filings/0000895126-26-000028.md) | [514 d](/filings/0000895126-26-000047.md) | [320 d](/filings/0000895126-26-000068.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [145](/filings/0000895126-24-000055.md) | [143](/filings/0000895126-24-000108.md) | [142](/filings/0000895126-24-000135.md) | [142](/filings/0000895126-25-000053.md) | [131](/filings/0000895126-25-000084.md) | [134](/filings/0000895126-25-000098.md) | [234](/filings/0000895126-26-000028.md) | [241](/filings/0000895126-26-000047.md) | [240](/filings/0000895126-26-000068.md) | [241](/filings/0000895126-26-000028.md) | [238](/filings/0000895126-26-000047.md) | [232](/filings/0000895126-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 230,957,348 at 2026-10-20, from the cover of the [10-Q filed 2026-10-27](/filings/0000895126-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 17:22 ET. No prices; not investment advice.